Authors

• Mark Hatherill (ORCID: https://orcid.org/0000-0003-3491-1809)
• Simbarashe Mabwe
• Ann M. Ginsberg (ORCID: https://orcid.org/0000-0002-4299-2031)
• Carly Young (ORCID: https://orcid.org/0000-0002-2338-8314)
• Eugenia Puentes
• Humphrey Mulenga (ORCID: https://orcid.org/0000-0002-2030-0751)
• Cadwill Pillay
• Hennie Geldenhuys (ORCID: https://orcid.org/0000-0002-2221-8997)
• Justin Shenje (ORCID: https://orcid.org/0000-0003-3054-3930)
• Claire Imbratta
• Frances Ratangee
• Marisa Russell
• Kathryn Rutkowski
• Nacho Aguiló (ORCID: https://orcid.org/0000-0001-7897-9173)
• Simon C. Mendelsohn (ORCID: https://orcid.org/0000-0002-4054-2766)
• Michèle Tameris (ORCID: https://orcid.org/0000-0002-7983-7203)
• Juana Doce
• Thomas J. Scriba (ORCID: https://orcid.org/0000-0002-0641-1359)
• Munyaradzi Musvosvi (ORCID: https://orcid.org/0000-0002-4526-8479)
• Virginie Rozot (ORCID: https://orcid.org/0000-0001-9757-1501)
• Dereck Tait (ORCID: https://orcid.org/0000-0002-8683-238X)
• Angelique Kany Kany Luabeya (ORCID: https://orcid.org/0000-0001-7379-2836)
• Esteban Rodríguez (ORCID: https://orcid.org/0000-0003-3277-6682)
• Michelle Fisher (ORCID: https://orcid.org/0000-0003-1414-7612)
• Nicole Bilek
• Ingrid Murillo Jelsbak
• Carlos Martı́n (ORCID: https://orcid.org/0000-0003-2993-5478)
• Devin Hunt
• Arrie Van Der Merve

Institutions

• Gates Foundation (US)
• Ingenieurgesellschaft Auto und Verkehr (Germany) (DE)
• University of Cape Town (ZA)
• Instituto de Salud Carlos III (ES)
• South African Tuberculosis Vaccine Initiative (ZA)
• Asociación de Investigación Metalúrgica del Noroeste (ES)
• Complejo Hospitalario de Pontevedra (ES)

Publication Details

Journal

The Lancet Global Health

Published

2025-04-15

DOI

https://doi.org/10.1016/s2214-109x(25)00046-4

Citations

12

Primary Topic

Tuberculosis Research and Epidemiology

Type

article

Field-Weighted Citation Impact

16.75

Funders

• International AIDS Vaccine Initiative
• National Institutes of Health
• Congressionally Directed Medical Research Programs